Epigenetic Scanner for Diagnosis and Command (E.S.D.C.)

Regenerative medicine has shown that the epigenetic state is plastic and, under controlled conditions, partly reversible. The ESDC (Epigenetic Scanner for Diagnosis and Command) is a conceptual platform that integrates: (i) acquisition and modelling of epigenetic maps based on multi‑omic and spatial data; (ii) an 'epigenetic command' module able to deliver safe and reversible molecular instructions; (iii) a selective elimination module to debulk pathological tissues; and (iv) a pro‑regenerative microenvironment. We propose the composite index ψ‑One to quantify the 'epigenetic order' of tissues and to steer therapeutic decisions with feedback. We outline the state of the art, current limitations (e.g., the lack of whole‑organ in‑vivo epigenetic imaging), a development roadmap, and safety/regulatory requirements. The goal is to enable in‑situ regeneration while reducing reliance on transplantation and large‑scale cell infusions. Note: this document summarizes conceptual elements associated with a provisional patent application filed at the USPTO in 2025

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-02
DOI
https://doi.org/10.5281/zenodo.17506985
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epigenetic Scanner for Diagnosis and Command (E.S.D.C.)

Zenodo (CERN European Organization for Nuclear Research)
Epigenetics and DNA Methylation
article

Epigenetic Scanner for Diagnosis and Command (E.S.D.C.)

article en

Abstract

Regenerative medicine has shown that the epigenetic state is plastic and, under controlled conditions, partly reversible. The ESDC (Epigenetic Scanner for Diagnosis and Command) is a conceptual platform that integrates: (i) acquisition and modelling of epigenetic maps based on multi‑omic and spatial data; (ii) an 'epigenetic command' module able to deliver safe and reversible molecular instructions; (iii) a selective elimination module to debulk pathological tissues; and (iv) a pro‑regenerative microenvironment. We propose the composite index ψ‑One to quantify the 'epigenetic order' of tissues and to steer therapeutic decisions with feedback. We outline the state of the art, current limitations (e.g., the lack of whole‑organ in‑vivo epigenetic imaging), a development roadmap, and safety/regulatory requirements. The goal is to enable in‑situ regeneration while reducing reliance on transplantation and large‑scale cell infusions. Note: this document summarizes conceptual elements associated with a provisional patent application filed at the USPTO in 2025

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 43%
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Epigenetic Scanner for Diagnosis and Command (E.S.D.C.) · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS